Literature DB >> 15615862

A highly conserved glycine within linker I and the extreme C terminus of G protein alpha subunits interact cooperatively in switching G protein-coupled receptor-to-effector specificity.

Evi Kostenis1, Lene Martini, James Ellis, Maria Waldhoer, Arne Heydorn, Mette M Rosenkilde, Pia K Norregaard, Rasmus Jorgensen, Jennifer L Whistler, Graeme Milligan.   

Abstract

Numerous studies have attested to the importance of the extreme C terminus of G protein alpha subunits in determining their selectivity of receptor recognition. We have previously reported that a highly conserved glycine residue within linker I is important for constraining the fidelity of receptor recognition by Galpha(q) proteins. Herein, we explored whether both modules (linker I and extreme C terminus) interact cooperatively in switching G protein-coupled receptor (GPCR)-to-effector specificity and created as models mutant Galpha(q) proteins in which glycine was replaced with various amino acids and the C-terminal five Galpha(q) residues with the corresponding Galpha(i) or Galpha(s) sequence. Coupling properties of the mutated Galpha(q) proteins were determined after coexpression with a panel of 13 G(i)-and G(s) -selective receptors and compared with those of Galpha proteins modified in only one module. Galpha proteins modified in both modules are significantly more efficacious in channeling non-G(q) -selective receptors to G(q)-mediated signaling events compare with those containing each module alone. Additive effects of both modules were observed even if individual modules lacked an effect on GPCR-to-effector specificity. Dually modified Galpha proteins were also superior in conferring high-affinity agonist sites onto a coexpressed GPCR in the absence, but not in the presence, of guanine nucleotides. Together, our data suggest that receptor-G protein coupling selectivity involves cooperative interactions between the extreme C terminus and linker I of Galpha proteins and that distinct determinants of selectivity exist for individual receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15615862     DOI: 10.1124/jpet.104.080424

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

Review 1.  Probing heterotrimeric G protein activation: applications to biased ligands.

Authors:  Colette Denis; Aude Saulière; Segolene Galandrin; Jean-Michel Sénard; Céline Galés
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Identification and functional comparison of seven-transmembrane G-protein-coupled BILF1 receptors in recently discovered nonhuman primate lymphocryptoviruses.

Authors:  Katja Spiess; Suzan Fares; Alexander H Sparre-Ulrich; Ellen Hilgenberg; Michael A Jarvis; Bernhard Ehlers; Mette M Rosenkilde
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

3.  Naturally occurring HCA1 missense mutations result in loss of function: potential impact on lipid deposition.

Authors:  Jamie R Doyle; Jacqueline M Lane; Martin Beinborn; Alan S Kopin
Journal:  J Lipid Res       Date:  2012-12-24       Impact factor: 5.922

4.  Pharmacological characterization of mouse GPRC6A, an L-alpha-amino-acid receptor modulated by divalent cations.

Authors:  B Christiansen; K B Hansen; P Wellendorph; H Bräuner-Osborne
Journal:  Br J Pharmacol       Date:  2007-01-22       Impact factor: 8.739

5.  Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist.

Authors:  Stephanie Hennen; Haibo Wang; Lucas Peters; Nicole Merten; Katharina Simon; Andreas Spinrath; Stefanie Blättermann; Rhalid Akkari; Ramona Schrage; Ralf Schröder; Daniel Schulz; Celine Vermeiren; Katrin Zimmermann; Stefan Kehraus; Christel Drewke; Alexander Pfeifer; Gabriele M König; Klaus Mohr; Michel Gillard; Christa E Müller; Q Richard Lu; Jesus Gomeza; Evi Kostenis
Journal:  Sci Signal       Date:  2013-10-22       Impact factor: 8.192

6.  The Ubiquitination of Spinal MrgC Alleviates Bone Cancer Pain and Reduces Intracellular Calcium Concentration in Spinal Neurons in Mice.

Authors:  Yu-E Sun; Hua-Ye Xu; Jing Hao; Wen-Wen Huo; Yue Qian; Bai-Ling Hou
Journal:  Neurochem Res       Date:  2019-09-12       Impact factor: 3.996

7.  Contribution of mu and delta opioid receptors to the pharmacological profile of kappa opioid receptor subtypes.

Authors:  D I Brissett; J L Whistler; R M van Rijn
Journal:  Eur J Pain       Date:  2011-12-19       Impact factor: 3.931

8.  Development of a membrane-anchored chemerin receptor agonist as a novel modulator of allergic airway inflammation and neuropathic pain.

Authors:  Jamie R Doyle; Subrahmanian T Krishnaji; Guangli Zhu; Zhen-Zhong Xu; Daniel Heller; Ru-Rong Ji; Bruce D Levy; Krishna Kumar; Alan S Kopin
Journal:  J Biol Chem       Date:  2014-03-21       Impact factor: 5.157

9.  Determinants involved in subtype-specific functions of rat trace amine-associated receptors 1 and 4.

Authors:  C Stäubert; J Bohnekamp; T Schöneberg
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

10.  A cell-permeable inhibitor to trap Gαq proteins in the empty pocket conformation.

Authors:  Anna-Lena Schmitz; Ramona Schrage; Evelyn Gaffal; Thomas H Charpentier; Johannes Wiest; Georg Hiltensperger; Julia Morschel; Stephanie Hennen; Daniela Häußler; Velten Horn; Daniela Wenzel; Manuel Grundmann; Katrin M Büllesbach; Ralf Schröder; H Henning Brewitz; Johannes Schmidt; Jesús Gomeza; Céline Galés; Bernd K Fleischmann; Thomas Tüting; Diana Imhof; Daniel Tietze; Michael Gütschow; Ulrike Holzgrabe; John Sondek; T Kendall Harden; Klaus Mohr; Evi Kostenis
Journal:  Chem Biol       Date:  2014-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.